ACRS
Aclaris Therapeutics Inc
3.70$
-13.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -140.6% | – | – | – | – | – | – | – | |
| – | +4.1% | +6.6% | -0.4% | -17.4% | -28.5% | -10.5% | -10.9% | -3.5% | -7.3% | +0.0% | +4.9% | – | |
| – | -78.7% | +65.0% | +39.0% | +3.5% | -4.8% | +23.6% | -13.4% | -6.6% | +2.3% | +9.3% | -16.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -167.8% | – | – | -103.9% | – | – | -19.4% | +428.8% | -150.2% | – | – | |
| – | +425.0% | -69.4% | -89.6% | -100.0% | – | -97.6% | -97.6% | +9.5% | +4.3% | -45.8% | +346.2% | – | |
| – | -76.8% | +123.0% | -104.0% | – | -3,274.3% | – | -73.6% | +174.0% | -25.0% | -398.3% | – | – | |
| – | – | -153.9% | -80.0% | -9.1% | +3,230.0% | -17.4% | -96.7% | – | -158.9% | – | – | – | |
| – | – | -212.2% | -80.0% | – | +338,900.0% | -100.4% | -96.7% | +33,722.2% | -16.8% | – | -99.8% | – | |
| – | -89.4% | -581.7% | – | – | -193.0% | – | -185.6% | – | – | – | -209.1% | – | |
| – | – | – | – | – | -303.4% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.